As of May 2022 Glaukos has a market cap of $1.88 Billion. This makes Glaukos the world's 3603th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.82 B | -12.25% |
2021 | $2.08 B | -38.42% |
2020 | $3.38 B | 42.8% |
2019 | $2.36 B | 16.83% |
2018 | $2.02 B | 128.75% |
2017 | $0.88 B | -22.95% |
2016 | $1.15 B | 44.83% |
2015 | $0.79 B |
On May 19th, 2022 the market cap of Glaukos was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() ICU Medical
ICUI | $4.33 B | 130.66% | ๐บ๐ธ USA |
![]() AtriCure ATRC | $1.98 B | 5.33% | ๐บ๐ธ USA |
![]() Integra LifeSciences IART | $4.98 B | 164.95% | ๐บ๐ธ USA |
![]() Hill-Rom HRC | $10.30 B | 447.70% | ๐บ๐ธ USA |